关注
Andres Sanchez Alberti
Andres Sanchez Alberti
在 docente.ffyb.uba.ar 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control
AE Bivona, AS Alberti, N Cerny, SN Trinitario, EL Malchiodi
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (5), 165658, 2020
662020
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
A Sanchez Alberti, AE Bivona, N Cerny, K Schulze, S Weißmann, ...
npj Vaccines 2 (1), 9, 2017
612017
Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine
AE Bivona, A Sánchez Alberti, MN Matos, N Cerny, AC Cardoso, ...
PLoS Neglected Tropical Diseases 12 (3), e0006384, 2018
422018
Oral Multicomponent DNA Vaccine Delivered by Attenuated Salmonella Elicited Immunoprotection Against American Trypanosomiasis
SI Cazorla, MN Matos, N Cerny, C Ramirez, AS Alberti, AE Bivona, ...
The Journal of Infectious Diseases 211 (5), 698-707, 2015
412015
Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.
LC Laurella, N Cerny, AE Bivona, A Sanchez Alberti, G Giberti, ...
PLoS Neglected Tropical Diseases 11 (9), e0005929, 2017
402017
Trypanocidal activity of four sesquiterpene lactones isolated from Asteraceae species
OG Elso, AE Bivona, A Sanchez Alberti, N Cerny, L Fabian, C Morales, ...
Molecules 25 (9), 2014, 2020
272020
Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
A Sanchez Alberti, AE Bivona, MN Matos, N Cerny, K Schulze, ...
Frontiers in Immunology 11, 128, 2020
272020
Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection
N Cerny, A Sanchez Alberti, AE Bivona, MC De Marzi, FM Frank, ...
Human vaccines & immunotherapeutics 12 (2), 438-450, 2016
262016
A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection
MN Matos, AS Alberti, C Morales, SI Cazorla, EL Malchiodi
Vaccine 34 (28), 3243-3251, 2016
242016
Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis
VP Sülsen, EF Lizarraga, OG Elso, N Cerny, A Sanchez Alberti, ...
Molecules 24 (7), 1209, 2019
212019
Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
N Cerny, AE Bivona, A Sanchez Alberti, SN Trinitario, C Morales, ...
Frontiers in immunology 11, 565142, 2020
192020
Preparation of sesquiterpene lactone derivatives: Cytotoxic activity and selectivity of action
MF Beer, AE Bivona, A Sánchez Alberti, N Cerny, GF Reta, VS Martín, ...
Molecules 24 (6), 1113, 2019
162019
Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens
AE Bivona, N Cerny, AS Alberti, SI Cazorla, EL Malchiodi
Vaccine Design: Methods and Protocols, Volume 2: Vaccines for Veterinary …, 2016
82016
Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection
MB Antonoglou, A Sánchez Alberti, DM Redolfi, AE Bivona, ...
Frontiers in Immunology 11, 1279, 2020
72020
Antitrypanosomal and antileishmanial activities
AS Alberti, N Cerny, A Bivona, SI Cazorla
Sesquiterpene Lactones: Advances in their Chemistry and Biological Aspects …, 2018
72018
In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection
AS Alberti, MF Beer, N Cerny, AE Bivona, L Fabian, C Morales, A Moglioni, ...
ACS omega 7 (1), 968, 2022
42022
In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection
A Sanchez Alberti, MF Beer, N Cerny, AE Bivona, L Fabian, C Morales, ...
ACS Omega 7 (1), 968-978, 2021
42021
Recombinant cysteine proteinase B from Leishmania braziliensis and its domains: promising antigens for serodiagnosis of cutaneous and visceral leishmaniasis in dogs
AE Bivona, L Czentner, A Sanchez Alberti, N Cerny, ...
Journal of Clinical Microbiology 57 (11), 10.1128/jcm. 00819-19, 2019
42019
Oxonitrogenated Derivatives of Eremophilans and Eudesmans: Antiproliferative and Anti-Trypanosoma cruzi Activity
MF Beer, GF Reta, A Puerta, AE Bivona, AS Alberti, N Cerny, ...
Molecules 27 (10), 3067, 2022
32022
Zika virus NS4B protein targets TANK-binding kinase 1 and inhibits type I interferon production
MB Sarratea, AS Alberti, DM Redolfi, SN Truant, LVI Lopez, AE Bivona, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1867 (12), 130483, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20